内部人交易记录
其他尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Explore the detailed record of transactions filed by Matin Shahriar. Officer active across 3 companies, notably REPRO MED SYSTEMS INC. In total, 23 disclosures have been recorded. History available since 30 June 2021. The latest transaction was filed on 1 April 2026 (Attribution). Regulator: SEC (Form 4). All data is openly available.
Companies and markets linked to Matin Shahriar
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报23 总计
3,472 股@ US$4.326.2% 占其流量Common StockSEC:0001161697-26-000083:0
2,581 股@ US$5.815.2% 占其流量Common StockSEC:0001161697-26-000012:0
3,916 股@ US$3.835.5% 占其流量Common StockSEC:0001161697-25-000338:0
4,189 股@ US$3.585.7% 占其流量Common StockSEC:0001161697-25-000203:0
5,870 股@ US$2.567.1% 占其流量Common StockSEC:0001161697-25-000134:0
3,937 股@ US$3.817.5% 占其流量Common StockSEC:0001161697-25-000021:0
5,454 股@ US$2.756.9% 占其流量Common StockSEC:0001161697-24-000409:0
5,545 股@ US$2.717.1% 占其流量Common StockSEC:0001161697-24-000309:0
6,329 股@ US$2.377.1% 占其流量Common StockSEC:0001161697-24-000172:0
6,329 股@ US$2.376.9% 占其流量Common StockSEC:0001161697-24-000011:0
5,263 股@ US$2.856.6% 占其流量Common StockSEC:0001161697-23-000606:0
5,484 股@ US$2.747.3% 占其流量Common StockSEC:0001161697-23-000520:0
4,310 股@ US$3.487.1% 占其流量Common StockSEC:0001161697-23-000394:0
3,521 股@ US$4.267.0% 占其流量Common StockSEC:0001161697-23-000237:0
3,521 股@ US$4.267.0% 占其流量Common StockSEC:0001161697-23-000217:0
4,273 股@ US$3.517.2% 占其流量Common StockSEC:0001161697-23-000028:0
6,681 股@ US$2.257.8% 占其流量Common StockSEC:0001161697-22-000497:0
6,002 股@ US$2.507.3% 占其流量Common StockSEC:0001161697-22-000342:0
5,221 股@ US$2.8729.5% 占其流量Common StockSEC:0001161697-22-000165:0
5,000 股@ US$3.0028.9% 占其流量Common StockSEC:0001161697-22-000016:0
5,263 股@ US$2.850.0048% mcap22.0% 占其流量Common StockSEC:0001161697-21-000594:0
5,263 股@ US$2.8528.3% 占其流量Common StockSEC:0001161697-21-000474:0
1,566 股@ US$4.6313.3% 占其流量Common StockSEC:0001161697-21-000336:0
About Matin Shahriar
Matin Shahriar is a declarant linked to KORU Medical Systems, Inc. and Repro MED Systems INC, where he is a director. The record contains 23 filings in total, and the 23 sampled filings cover the period from 2021-07-06 to 2026-04-01, with buy and sell volumes shown as 0 each. The modal transaction nature is Attribution.